We were wondering if big pharmaceutical companies are adverse to the disruptive element of innovation. So, we asked our Zintro experts what they thought. Pradeep Oza, an expert in pharmaceutical marketing, thinks that big pharma companies are not adverse to innovation; the issues are timelines and the financial risks a company has to take. “Developed [...]